For a primary care physician in Mexico City or São Paulo, the clinical day doesn't end when the last patient leaves the office. It continues, relentlessly, in the green bubble of a WhatsApp chat. Appointment requests, medication questions, lab results, and follow-up photos spill into a single, chaotic stream alongside messages from family and friends. The burden is real, unremunerated, and a primary driver of burnout. Leona Health, a Mexico City-based startup, isn't trying to replace that channel. Instead, it's building an AI layer directly on top of it, aiming to turn a source of administrative chaos into a manageable clinical workflow.
Founded in 2023, Leona has secured $14 million in seed funding led by Andreessen Horowitz to pursue this wedge [VentureCapital.com, 2025 (estimated)]. The product is an assistant that integrates with a doctor's existing WhatsApp number. It ingests incoming messages, prioritizes them by urgency, drafts suggested responses for review, and helps organize patient lists and tasks [MEXC News, Unknown]. Early users report saving two to three hours daily previously spent managing this communication [mexc.com, Unknown]. For Pulse Raman, the patient-centric angle is clear: when a doctor is drowning in unstructured messages, the risk of a critical update being missed rises. Leona's bet is that by giving clinicians back those hours, it can improve both practitioner well-being and the consistency of care.
The Wedge Is the Channel
Leona's strategy is defined by a clear geographic and behavioral insight. In many parts of Latin America, WhatsApp is not just a convenient tool; it is the default, trusted medium for doctor-patient communication. Attempting to migrate those conversations to a proprietary portal or a feature within an electronic health record (EHR) is often a non-starter. Leona meets the user where they already are. Its AI co-pilot operates within the WhatsApp environment doctors and patients already use, requiring no change in behavior from either party [MEXC News, Unknown]. This drastically lowers the adoption barrier. The company claims it is now active with doctors across 14 countries and more than 22 medical specialties, suggesting the pain point is widespread [tucson.com, 2026].
A Team Built for Scale and Context
The founding team brings a blend of operational scale, technical depth, and regional expertise critical for navigating this complex market.
| Role | Name | Key Background |
|---|---|---|
| Founder & CEO | Caroline Merin | Former COO of Rappi, Uber Eats alum [MEXC News, Unknown] |
| Chief Technology Officer | Tom Chokel | Former Google AdWords engineer, co-founder of Modern Fertility [TechCrunch, 2013] [Crunchbase, Unknown] |
| Head of Operations | Arela Solis | Former program leader for Latin America at Elevation W, roles in social innovation and business strategy [theorg.com, 2026] |
Merin's experience scaling Rappi, a Latin American super-app, provides a foundational understanding of building and operating complex, high-volume platforms in the region. Chokel's background in both large-scale systems at Google and healthtech at Modern Fertility bridges the technical and clinical domains. Solis adds deep roots in Latin American venture and social impact, rounding out a team that appears designed to execute on a region-specific product bet.
The Investor Conviction
The $14 million seed round is notable not just for its size but for its composition. Andreessen Horowitz (a16z) led the round, with participation from General Catalyst and Accel [theaiinsider.tech, 2025]. The investor list also includes individual checks from Kate Ryder (founder of Maven Clinic), David Vélez (founder of Nubank), and Simón Borrero (co-founder of Rappi) [MEXC News, Unknown]. This syndicate signals strong belief in both the team and the specific market wedge. The presence of Ryder, a pioneer in digital health, and Vélez and Borrero, who built category-defining companies in Latin American fintech and delivery, offers a powerful blend of healthtech and regional scaling wisdom.
Navigating the Inherent Risks
For all its promising traction, Leona's path is not without significant hurdles that will define its next phase. The company's success hinges on executing a difficult balancing act across several fronts.
- Clinical accuracy and liability. An AI drafting medical responses operates in a high-stakes domain. While the doctor remains the final reviewer, any suggestion that leads to a miscommunication or delayed care carries profound risk. The company has not publicly detailed its model's training data, guardrails, or any regulatory clearances, which will be a key area of scrutiny as it scales.
- Monetization and expansion. The initial focus on individual and small-group practices in Latin America is a smart wedge. The long-term play, however, likely involves moving upstream to larger clinics and health systems, which have more complex workflows, procurement cycles, and integration needs with existing EHRs. This is a different sales motion entirely.
- Competitive response. While no direct competitors are named in the sources, the space is attracting attention. Large telehealth platforms, EHR vendors, and even Meta itself could introduce similar features natively into WhatsApp Business, potentially eroding Leona's unique value proposition.
Leona's most plausible answer to these challenges lies in the depth of its dataset and network effects. Every interaction processed makes its prioritization and drafting smarter for all doctors in a given specialty. If it can achieve critical mass and demonstrate clear outcomes, it becomes a sticky, intelligence layer that is harder to displace with a generic feature.
The Road Ahead
The immediate roadmap appears focused on scaling its existing wedge. The company is hiring for a Head of Growth, indicating a push to systematize its sales and customer success playbooks [Built In NYC, Unknown]. The seed funding provides a substantial runway to prove unit economics and deepen its product moat before a likely Series A. Key milestones to watch will be published outcomes data, a move into larger enterprise contracts, and any announcements regarding partnerships with regional health providers or payers.
The patient population here is broad, encompassing anyone under the care of a physician using Leona, from someone managing chronic hypertension to a parent seeking pediatric advice. The disease state, in a sense, is administrative overload and its downstream effects on care quality. The standard of care today in much of Latin America is an ad-hoc, exhausting, and error-prone process conducted over a consumer messaging app not designed for clinical triage. Doctors are forced to be their own secretaries, sorting vital updates from casual check-ins, often during personal time. Leona Health is betting that the most effective way to fix this isn't to build a new channel, but to bring order to the one that already exists.
Sources
- [VentureCapital.com, 2025 (estimated)] Leona Health funding news | https://venturecapital.com/news/
- [MEXC News, Unknown] Leona Health’s Revolutionary $14M Seed Funding: How AI Conquers WhatsApp Chaos for Latin American Doctors | https://www.mexc.co/en-NG/news/283079
- [mexc.com, Unknown] Early user reports on time savings | https://www.mexc.co/en-NG/news/283079
- [tucson.com, 2026] Leona Health active across 14 countries | https://tucson.com
- [theaiinsider.tech, 2025] Leona Health $14M seed round details | https://theaiinsider.tech
- [TechCrunch, 2013] Tom Chokel role at AdStage | https://techcrunch.com/2013/06/21/adstage-acquires-semply/
- [Crunchbase, Unknown] Tom Chokel co-founder of Modern Fertility | https://www.crunchbase.com/organization/leona-f1b5
- [theorg.com, 2026] Arela Solis background | https://theorg.com
- [a16z.com, Unknown] Andreessen Horowitz announcement on investing in Leona | https://a16z.com/announcement/investing-in-leona/